Microsomal metabolism of erythraline: an anxiolitic spiroalkaloid
Marques, Lucas Maciel Mauriz, Aguiar, Fernando Armani, Silva, Denise Brentan da, Callejon, Daniel Roberto, Oliveira, Anderson Rodrigo Moraes de, Lopes, Norberto Peporine, Lopes, João Luís Callegari, Guaratini, Thais
Rev. bras. farmacogn.
DATA DE PUBLICAÇÃO
ABSTRACTThe genus Erythrina, Fabaceae, is widely distributed in tropical and subtropical regions. Their flowers, fruits, seeds and bark are frequently used in folk medicine for its effects on the central nervous system such as anticonvulsant, antidepressant, analgesic, sedative, and hypnotic effects. Erythraline has been reported as one of the active compounds from Erythrina, but until now there are no pharmacokinetics data about this compound and only few results showing a putative metabolism were reported. To improve the information about erythraline metabolism, this article reports and discusses, for the first time, the in vitrometabolism biotransformation of erythraline by cytochrome P450 enzymes.
- Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid.
- Induction of microsomal drug metabolism in man and in the rat by exposure to petroleum.
- Effect of repeated exposure to aniline, nitrobenzene, and benzene on liver microsomal metabolism in the rat.
- Protein translocation across wheat germ microsomal membranes requires an SRP-like component
- Stimulation of bilirubin catabolism in jaundiced Gunn rats by an inducer of microsomal mixed-function monooxygenases*